420 related articles for article (PubMed ID: 9472210)
1. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration.
Armstrong DG; Lavery LA; Vela SA; Quebedeaux TL; Fleischli JG
Arch Intern Med; 1998 Feb; 158(3):289-92. PubMed ID: 9472210
[TBL] [Abstract][Full Text] [Related]
2. Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Impact on prevalence of insensate foot and workload requirements.
McGill M; Molyneaux L; Spencer R; Heng LF; Yue DK
Diabetes Care; 1999 Apr; 22(4):598-602. PubMed ID: 10189538
[TBL] [Abstract][Full Text] [Related]
3. Role of neuropathy and high foot pressures in diabetic foot ulceration.
Frykberg RG; Lavery LA; Pham H; Harvey C; Harkless L; Veves A
Diabetes Care; 1998 Oct; 21(10):1714-9. PubMed ID: 9773736
[TBL] [Abstract][Full Text] [Related]
4. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial.
Pham H; Armstrong DG; Harvey C; Harkless LB; Giurini JM; Veves A
Diabetes Care; 2000 May; 23(5):606-11. PubMed ID: 10834417
[TBL] [Abstract][Full Text] [Related]
5. Which diabetic patients should receive podiatry care? An objective analysis.
McGill M; Molyneaux L; Yue DK
Intern Med J; 2005 Aug; 35(8):451-6. PubMed ID: 16176466
[TBL] [Abstract][Full Text] [Related]
6. Identification of patients at risk for diabetic foot: a comparison of standardized noninvasive testing with routine practice at community diabetes clinics.
Jirkovská A; Boucek P; Wosková V; Bartos V; Skibová J
J Diabetes Complications; 2001; 15(2):63-8. PubMed ID: 11274901
[TBL] [Abstract][Full Text] [Related]
7. Screening patients at risk for diabetic foot ulceration: a comparison between measurement of vibration perception threshold and 10-g monofilament test.
Richard JL; Reilhes L; Buvry S; Goletto M; Faillie JL
Int Wound J; 2014 Apr; 11(2):147-51. PubMed ID: 22892021
[TBL] [Abstract][Full Text] [Related]
8. Testing for loss of protective sensation in patients with foot ulceration: a cross-sectional study.
Wood WA; Wood MA; Werter SA; Menn JJ; Hamilton SA; Jacoby R; Dellon AL
J Am Podiatr Med Assoc; 2005; 95(5):469-74. PubMed ID: 16166466
[TBL] [Abstract][Full Text] [Related]
9. The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes.
Mayfield JA; Sugarman JR
J Fam Pract; 2000 Nov; 49(11 Suppl):S17-29. PubMed ID: 11093555
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of factors associated with extremity ulceration in diabetic subjects with peripheral neuropathy].
Porciúncula MV; Rolim LC; Garofolo L; Ferreira SR
Arq Bras Endocrinol Metabol; 2007 Oct; 51(7):1134-42. PubMed ID: 18157390
[TBL] [Abstract][Full Text] [Related]
11. Simple screening tests for peripheral neuropathy in the diabetes clinic.
Perkins BA; Olaleye D; Zinman B; Bril V
Diabetes Care; 2001 Feb; 24(2):250-6. PubMed ID: 11213874
[TBL] [Abstract][Full Text] [Related]
12. 4.5-gram monofilament sensation beneath both first metatarsal heads indicates protective foot sensation in diabetic patients.
Saltzman CL; Rashid R; Hayes A; Fellner C; Fitzpatrick D; Klapach A; Frantz R; Hillis SL
J Bone Joint Surg Am; 2004 Apr; 86(4):717-23. PubMed ID: 15069135
[TBL] [Abstract][Full Text] [Related]
13. Easier operation and similar power of 10 g monofilament test for screening diabetic peripheral neuropathy.
Zhang Q; Yi N; Liu S; Zheng H; Qiao X; Xiong Q; Liu X; Zhang S; Wen J; Ye H; Zhou L; Li Y; Hu R; Lu B
J Int Med Res; 2018 Aug; 46(8):3278-3284. PubMed ID: 29808737
[TBL] [Abstract][Full Text] [Related]
14. Screening diabetic patients at risk for foot ulceration. A multi-centre hospital-based study in France.
Malgrange D; Richard JL; Leymarie F;
Diabetes Metab; 2003 Jun; 29(3):261-8. PubMed ID: 12909814
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening.
Kamei N; Yamane K; Nakanishi S; Yamashita Y; Tamura T; Ohshita K; Watanabe H; Fujikawa R; Okubo M; Kohno N
J Diabetes Complications; 2005; 19(1):47-53. PubMed ID: 15642490
[TBL] [Abstract][Full Text] [Related]
16. Interpreting the results of the Semmes-Weinstein monofilament test: accounting for false-positive answers in the international consensus on the diabetic foot protocol by a new model.
Slater RA; Koren S; Ramot Y; Buchs A; Rapoport MJ
Diabetes Metab Res Rev; 2014 Jan; 30(1):77-80. PubMed ID: 23996640
[TBL] [Abstract][Full Text] [Related]
17. Moisture status of the skin of the feet assessed by the visual test neuropad correlates with foot ulceration in diabetes.
Tentolouris N; Voulgari C; Liatis S; Kokkinos A; Eleftheriadou I; Makrilakis K; Marinou K; Katsilambros N
Diabetes Care; 2010 May; 33(5):1112-4. PubMed ID: 20150296
[TBL] [Abstract][Full Text] [Related]
18. Dryness of Foot Skin Assessed by the Visual Indicator Test and Risk of Diabetic Foot Ulceration: A Prospective Observational Study.
Panagoulias GS; Eleftheriadou I; Papanas N; Manes C; Kamenov Z; Tesic D; Bousboulas S; Tentolouris A; Jude EB; Tentolouris N
Front Endocrinol (Lausanne); 2020; 11():625. PubMed ID: 33013702
[No Abstract] [Full Text] [Related]
19. Sensory thresholds of normal human feet.
Jeng C; Michelson J; Mizel M
Foot Ankle Int; 2000 Jun; 21(6):501-4. PubMed ID: 10884110
[TBL] [Abstract][Full Text] [Related]
20. Validation of bedside methods in evaluation of diabetic peripheral neuropathy.
Jayaprakash P; Bhansali A; Bhansali S; Dutta P; Anantharaman R; Shanmugasundar G; Ravikiran M
Indian J Med Res; 2011 Jun; 133(6):645-9. PubMed ID: 21727664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
